SCHEMBL22018420

SCHEMBL22018420

O=C(Nc1cnc2sccc2c1C1CCCCCCCC1)c1ccccccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ADCY1 Q08828 1/20 0.44
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CCR8 P51685 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NR2F2 P24468 1/20 0.40
STAT3 P40763 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SCD O00767 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CHRNA7 P36544 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
GSK3A P49840 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18399551 0.83 STK17B (0.48) RAB9ASMN1; SMN2HDAC2
SCHEMBL20368696 0.83 STK17B (0.48) RAB9ASMN1; SMN2HDAC2
SCHEMBL22018149 0.82 KDM4E (0.50) KDM4EADCY1NPC1RAB9AMEN1
SCHEMBL18399529 0.81 MALT1 (0.52) KDM4EADCY1CCR8L3MBTL1
SCHEMBL18399586 0.79 PARP1 (0.47) KDM4EADCY1NPC1RAB9ACCR8
SCHEMBL21157772 0.73 ADCY1 (0.44) KDM4EADCY1NPC1RAB9ACCR8
SCHEMBL18399571 0.72 ADCY1 (0.46) KDM4EADCY1NPC1RAB9ACCR8
SCHEMBL22018237 0.71 ADCY1 (0.42) KDM4EADCY1NPC1RAB9ACCR8
SCHEMBL18399585 0.71 ADCY1 (0.42) KDM4EADCY1NPC1RAB9ACCR8
SCHEMBL22138677 0.67 MALT1 (0.54) KDM4ERAB9AMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 KDM4E 913/4885ADCY1 1867/4885NPC1 2615/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 KDM4E 913/4885ADCY1 1867/4885NPC1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.